MAM
Frido Is the official insole partner for the T20 League
Mumbai: Frido, a leading Indian consumer healthcare brand, announces a new collaboration with Royal Challengers Bengaluru (RCB), marking the first-ever partnership between an insole brand and a T20 League team. This collaboration also includes the launch of a special edition sports insole and technical socks which will be launched in collaboration with RCB and aimed at managing knee and foot injuries like plantar fasciitis, and heel, and lower body pain.
Based out of Pune, Frido makes orthotic insoles, cloud insoles, and orthopaedic heel pads, amongst other lifestyle products such as seat cushions, pillows, and face masks. The insoles can be trimmed to fit the shoes of the user.
This is the first of its kind of partnership between an insole brand and an IPL team. This collaboration also includes the launch of a special edition sports insole and many more exciting product ranges designed in partnership with RCB and aimed at enhancing performance and arch support for athletes and sports enthusiasts.
Frido has long been recognized for its extensive range of high-quality insoles tailored to specific needs, including those for sports. With the forthcoming addition of sports socks to its lineup, Frido continues solidifying its position as the go-to brand for superior foot care solutions. From specialized wheelchairs to gel insoles for everyday shoes, Frido has consistently delivered innovative products to its customers.
Frido Co-founder and CEO Ganesh Sonawane said, “With this insole, we have extended our expertise to the field of sports, ensuring athletes have access to the best possible equipment for optimal performance while reducing foot and knee pain. And getting the opportunity to collaborate with Royal Challengers Bengaluru is a dream come true.”
Royal Challengers Bengaluru vice president & head Rajesh Menon said, “We are pleased to partner with Frido. As a brand committed to enhancing freedom and comfort while playing, Frido’s products are an excellent addition to the equipment used by our athletes.”
The collaboration with RCB underscores Frido’s dedication to innovation and excellence. Leveraging their expertise in technical footwear, Frido aims to support RCB players and fans in achieving their performance goals while minimizing the risk of lower body pain and injuries.
Stay tuned for more updates from Frido and Royal Challengers Bengaluru as they join forces to redefine standards of innovative athletic solutions. For more information about Frido and its range of creative.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
